BTK and lymphoma: They reported that BGB-16673 had a nanomolar IC50 and effected BTK protein degradation in each of these TMD8 lymphoma cell lines, except for those with the BTK A428D mutation, suggesting that BGB-16673 interacts with BTK at or around A428.